Sustainable Growth Advisers LP Buys Shares of 3,385,059 The Cooper Companies, Inc. $COO

Sustainable Growth Advisers LP purchased a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, HoldingsChannel.com reports. The fund purchased 3,385,059 shares of the medical device company’s stock, valued at approximately $240,881,000.

Several other large investors have also bought and sold shares of the business. Zions Bancorporation National Association UT acquired a new stake in Cooper Companies during the 1st quarter worth $33,000. GKV Capital Management Co. Inc. bought a new position in shares of Cooper Companies in the 1st quarter worth $40,000. J.Safra Asset Management Corp grew its stake in shares of Cooper Companies by 204.8% during the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock worth $36,000 after purchasing an additional 340 shares during the period. Assetmark Inc. increased its holdings in Cooper Companies by 357.8% in the second quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock valued at $44,000 after purchasing an additional 483 shares during the last quarter. Finally, Larson Financial Group LLC lifted its stake in Cooper Companies by 1,071.0% in the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company’s stock valued at $61,000 after buying an additional 664 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on COO shares. JPMorgan Chase & Co. lowered their target price on shares of Cooper Companies from $76.00 to $66.00 and set a “neutral” rating for the company in a research note on Thursday, August 28th. BNP Paribas upgraded Cooper Companies from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 22nd. Morgan Stanley set a $76.00 price objective on Cooper Companies and gave the company an “equal weight” rating in a report on Thursday, August 28th. Barclays initiated coverage on shares of Cooper Companies in a report on Monday, October 13th. They issued an “overweight” rating and a $85.00 price target for the company. Finally, BNP Paribas Exane upgraded shares of Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 price objective on the stock in a report on Tuesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $84.77.

Insider Transactions at Cooper Companies

In other news, Director Lawrence Erik Kurzius acquired 2,000 shares of Cooper Companies stock in a transaction dated Monday, September 29th. The stock was bought at an average price of $68.39 per share, for a total transaction of $136,780.00. Following the completion of the acquisition, the director directly owned 5,777 shares in the company, valued at approximately $395,089.03. The trade was a 52.95% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Albert G. White III bought 10,000 shares of the firm’s stock in a transaction dated Friday, September 5th. The stock was purchased at an average cost of $68.39 per share, for a total transaction of $683,900.00. Following the transaction, the chief executive officer directly owned 226,151 shares of the company’s stock, valued at $15,466,466.89. The trade was a 4.63% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last 90 days, insiders acquired 17,975 shares of company stock valued at $1,216,346. Corporate insiders own 1.98% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO opened at $72.13 on Friday. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The firm has a 50-day moving average of $69.70 and a 200-day moving average of $72.37. The company has a market cap of $14.34 billion, a PE ratio of 35.53, a price-to-earnings-growth ratio of 1.83 and a beta of 1.02. The Cooper Companies, Inc. has a one year low of $61.78 and a one year high of $106.63.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the previous year, the business earned $0.96 earnings per share. The business’s revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies announced that its board has authorized a share buyback program on Wednesday, September 17th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the medical device company to reacquire up to 15.4% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s board believes its shares are undervalued.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.